Welcome to my Corona Death Analysis
*Note because the chart was inserted as an image, the scaling may have shifted slightly, simply scale at the right edge until the orange zero matches the zero line of the chart.
First of all, I know Corona is a delicate subject and also that I analyze the deaths here seems to work a macabre, but the fact is that the numbers...
Hi guys, I think Moderna will go up again and get a trend change up. Today Moderna breaks out of the trenchannel and the rsi has also potential for going up. If the chart goes over the EMAs than it get also from them supported and have a good chance to go up again.
what you guys think?
Fundamental
Quidel: a manufacturer of diagnostic products, frequently rises or sinks in response to developments in the coronavirus pandemic, as a big part of their revenue comes from its COVID-19 testing kits.
As the Delta Variant is worrying countries around the globe, QDEL will be interesting to watch.
Technical Analysis
As you can see in the weekly ...
VXA-CoV2-1, Vaxart's experimental treatment for Covid-19 is unique in that it's a pill, not an injection.
A pill would certainly be easier from a distribution and administration standpoint but also to get higher vaccination rates.
On May 3, Vaxart's treatment showed demonstrable CD8 T-cell responses, but didn't produce high levels of neutralizing antibodies...
Why $IFMK Skyrocketed in February
There does not appear to be any direct news from the company. But it seems like that there was some coordination by day traders on social media.
$IFMK shares were buoyed — thanks to discussions and speculation on Twitter and Twitter hashtags at the start of the month.
iFresh Inc is an Asian/Chinese grocery supermarket chain in...
A little-known biotech is trying its hand at developing a coronavirus vaccine. Can it succeed?
over the past year, Vaxart stock has soared over 1,250% because of its spot in the lucrative coronavirus vaccine race.
Its stock performance even outpaced those of biotechs that have already brought their coronavirus vaccines to market, such as Moderna and...
Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19
announced today the submission of an Investigational New Drug (IND) to FDA for the investigational use of Tempol for the treatment of Coronavirus (COVID-19).
The submission of the IND to FDA followed a Pre-IND meeting with FDA in which FDA gave specific...
I am not swinging this one, even though it is tempting.
I recently sold NVAX at 15% profit, and due to strong correlation with MRNA I was considering selling my MRNA as well, in which case I would have made 14% right now.
However, I decided to hold because of 2 reasons :
1) AstraZeneca just took a major hit (if you don't know about it, catch up on the news)....
Right now is a good moment to stack up some acorda stock's & in the future I will come up with an exit plan.
I see 1000-2000% Growth potential in this stock.
Invest @ 0.75$ and the risk is minimal.
$ADGS New CEO listed and $200,000 in Taxes paid to get the company up to date on filings. Usually when this happens there's a good reason for it such as a potential R/M and a big one. So far there's been several Xu connections; One to a medical company that is dealing with the Corona-virus, a large Burger Franchise overseas and a large tech company. There is no...
